Finance

Lists
URGN:NASDAQ
Urogen Pharma Ltd
US$ ३६.६०
+०.०५%
(+०.०२०) 1D
अक्टोबर १५, १५:४०:५४ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for URGN...
Open
US$ ३७.०४
High
US$ ३८.३७
Low
US$ ३६.२७
Mkt. cap
१.७९ अरब
Avg. vol.
९.०४ लाख
Volume
२.९१ लाख
52-wk high
US$ ५०.८१
52-wk low
US$ १६.३६
EPS
-US$ १.९८
Beta
१.५७
Shares outstanding
४.८९ करोड
No. of employees
३००
Open
US$ ३७.०४
High
US$ ३८.३७
Low
US$ ३६.२७
Mkt. cap
१.७९ अरब
Avg. vol.
९.०४ लाख
Volume
२.९१ लाख
52-wk high
US$ ५०.८१
52-wk low
US$ १६.३६
EPS
-US$ १.९८
Beta
१.५७
Shares outstanding
४.८९ करोड
No. of employees
३००
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
७ घण्टा पहिले
MarketBeat cites USD 52.38 target for UroGen Pharma stock
Stock Traders Daily
Stock Traders Daily
·
१ दिन पहिले
(URGN) Risk Channels and Responsive Allocation
About Urogen Pharma Ltd
CEO-
Employees३००
Founded२००४
Headquartersन्यू योर्क शहर, न्यू योर्क, संयुक्त राज्य अमेरिका
Sector-
Websiteurogen.com
Analyst ratings
Based on 5 analysts giving stock ratings to URGN in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for URGN in the last 3 months.
Highest
Current US$ ३६.६०
US$ ७५.०० (+१०४.९२%)
Average
US$ ६०.२० (+६४.४८%)
Lowest
US$ ४८.०० (+३१.१५%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
US$ ७५.००
+१०४.९%
08/21/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
US$ ६०.००
+६३.९%
08/06/2026
Paul Choi
Goldman Sachs
Hold
Maintained
US$ ४८.००
+३१.१%
08/05/2026
Michael Schmidt
Guggenheim
Buy
Maintained
US$ ५८.००
+५८.५%
08/05/2026
Tara Bancroft
TD Cowen
Buy
Reiterated
US$ ६०.००
+६३.९%
08/05/2026
Unknown Analyst
Guggenheim
Buy
Maintained
US$ ३२.००
-१२.६%
06/03/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Initiated
US$ ४३.००
+१७.५%
05/11/2026
Kelsey Goodwin
Piper Sandler
Buy
Maintained
US$ ४०.००
+९.३%
04/20/2026
Amin Makarem
Jefferies
Buy
Initiated
US$ ४०.००
+९.३%
04/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२.७५ करोड
३.७८ करोड
५.१० करोड
७.२५ करोड
Cost of goods sold
३२.७८ लाख
३२.८९ लाख
४१.३९ लाख
६५.७२ लाख
Cost of revenue
३२.७८ लाख
३२.८९ लाख
४१.३९ लाख
६५.७२ लाख
Research and development expenses
१.४० करोड
१.४३ करोड
१.५६ करोड
१.७३ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३.७६ करोड
३.९३ करोड
५.१५ करोड
४.८४ करोड
Operating expense
५.१६ करोड
५.३७ करोड
६.७१ करोड
६.५८ करोड
Total operating expenses
५.४९ करोड
५.७० करोड
७.१२ करोड
७.२३ करोड
Operating income
-२.७४ करोड
-१.९१ करोड
-२.०३ करोड
१.११ लाख
Other non operating income
-४८.१८ लाख
-४६.६० लाख
-४८.२९ लाख
-४८.९२ लाख
EBT including unusual items
-३.४४ करोड
-२.६६ करोड
-२.८३ करोड
-८७.२२ लाख
EBT excluding unusual items
-३.४४ करोड
-२.६६ करोड
-२.८३ करोड
-८७.२२ लाख
Income tax expense
-१०.५४ लाख
-२.७५ लाख
-४७.७२ लाख
५६.२९ लाख
Effective tax rate
३.०६%
१.०३%
१६.८३%
-६४.५४%
Other operating expenses
-
-
-
-
Net income
-३.३३ करोड
-२.६४ करोड
-२.३६ करोड
-१.४४ करोड
Net profit margin
-१२१.३४%
-६९.६८%
-४६.२६%
-१९.८१%
Earnings per share
-०.६९
-०.५३
-०.४७
-०.२८
Interest and investment income
११.७६ लाख
९.०८ लाख
९.३१ लाख
९.४६ लाख
Interest expense
-३३.७३ लाख
-३७.७२ लाख
-४१.८५ लाख
-४८.८७ लाख
Net interest expenses
-२१.९७ लाख
-२८.६४ लाख
-३२.५४ लाख
-३९.४१ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-२.७३ करोड
-१.९० करोड
-२.०२ करोड
१.८९ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू